Alacepril
An ACE inhibitor used in the treatment of hypertension and heart failure
{{Drugbox | verifiedfields = changed | verifiedrevid = 477002679 | IUPAC_name = (2S)-1-[(2S)-2-[[2-[[2-(acetylsulfanyl)acetyl]amino]acetyl]amino]-3-phenylpropanoyl]pyrrolidine-2-carboxylic acid | image = Alacepril.svg | image2 = Alacepril_synthesis.svg | width2 = 250 }}
Alacepril is a medication that belongs to the class of angiotensin-converting enzyme inhibitors (ACE inhibitors). It is primarily used in the management of hypertension and heart failure.
Mechanism of action[edit]
Alacepril works by inhibiting the angiotensin-converting enzyme (ACE), which is responsible for the conversion of angiotensin I to angiotensin II. Angiotensin II is a potent vasoconstrictor that increases blood pressure by causing blood vessels to constrict. By inhibiting this enzyme, alacepril reduces the formation of angiotensin II, leading to vasodilation and a subsequent decrease in blood pressure.
Pharmacokinetics[edit]
Alacepril is administered orally and is absorbed in the gastrointestinal tract. It is a prodrug, which means it is converted into its active form, enalaprilat, in the body. The conversion occurs primarily in the liver. The active metabolite enalaprilat is responsible for the therapeutic effects of alacepril.
Clinical uses[edit]
Alacepril is used in the treatment of:
- Hypertension: By lowering blood pressure, alacepril helps reduce the risk of stroke, myocardial infarction, and kidney failure.
- Heart failure: It helps improve symptoms and reduce the risk of hospitalization in patients with heart failure.
Side effects[edit]
Common side effects of alacepril include:
- Cough
- Hyperkalemia (elevated potassium levels)
- Hypotension (low blood pressure)
- Dizziness
Less common but serious side effects include:
Contraindications[edit]
Alacepril is contraindicated in patients with:
- A history of angioedema related to previous treatment with an ACE inhibitor
- Pregnancy, due to the risk of fetal harm
Related pages[edit]
Gallery[edit]
-
Chemical structure of Alacepril
-
Synthesis of Alacepril
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian